Evaluation of the British Columbia Exemption to Allow for Personal Possession of Small Amounts of Illegal Drugs: Semi-annual Meeting
What We Heard Report

Meeting Date: November 23, 2023
Location: Virtual Meeting

Introduction

This funding opportunity was designed to enable an independent evaluation of the British Columbia (B.C.) exemption from subsection 56 (1) of Canada’s Controlled Drugs and Substances Act, which came into effect on January 31, 2023.

Background information on the funding opportunity and the Canadian Research Initiative in Substance Misuse (CRISM) Ontario Node team leading this five-year policy evaluation project can be found on CIHR’s website and the CRISM Ontario website.

CIHR-Institute of Neurosciences, Mental Health and Addiction (INMHA) is committed to knowledge mobilization and has generated this report to summarize the study’s progress to date, as presented by the research team at an update meeting on November 23, 2023.

The next update is expected in spring/summer 2024.

Evaluation Goals

  1. Generate evidence on the public health and economic impact of decriminalization through engaging stakeholder groups, including people who use drugs (PWUD), the general population, police forces, and the criminal justice system;
  2. Foster cross-disciplinary collaboration with decision makers and knowledge users to address pressing evidence needs and inform drug policy;
  3. Consider the local context and other factors, such as biological and social determinants (e.g., sex, gender, age, housing status and income, etc.) and sub-populations (e.g., rural/urban, etc.) ;
  4. Identify considerations for further evaluation activities, including insights and generalizable knowledge regarding implementation processes, barriers, and facilitators; and
  5. Advance evidence-based practices through knowledge dissemination activities.

Progress Summary

Since the research team’s first update, the project has focused on establishing partnerships with relevant knowledge users and researchers. Based on these collaborations, data-sharing agreements have been submitted to access specific data required for analyses. Working groups for each sub-study have been assembled, comprising experts, including people with lived and living experience (PWLLE) who have contributed to study design, proposal development, and will be integral in the implementation. Legal and administrative agreements with a range of partners, including the BC Centre for Disease Control (BCCDC), Statistics Canada, the Canadian Institute for Health Information (CIHI), and researchers from Simon Fraser University (SFU), have been initiated. Research ethics applications have been submitted for all upcoming sub-projects at relevant host institutions. This research project is comprised of several interrelated quantitative and qualitative sub-studies that have been designed to evaluate key areas of research. More information on the study design.

Progress updates and results (where available) for each of the sub-studies are summarized below.

Impact of Decriminalization on People Who Use Drugs

This sub-study is using quantitative analyses and qualitative interviews to examine health impacts and experiences with decriminalization among people who use drugs (PWUD).

Qualitative Sub-Study

PWUD perceptions on decriminalization prior to the policy coming into effect

Between June and October 2022, 45 PWUD from across B.C. were interviewed regarding their perceptions on decriminalization. The results of this study were published in the journal Substance Abuse Treatment, Prevention and Policy in June 2023Footnote 1. A research snapshot summarizing the study can be found online here.

Key findings can be summarized under two main themes:

Implications of threshold on substance use behaviours and purchasing patterns:

Implications of threshold on police enforcement, use of discretion, and jurisdictional discrepancies

Summary

PWUD perceptions on decriminalization after the policy came into effect

Interviews with PWUD began in October 2023 and are ongoing, with 55 completed at the time of this update. The goal of this part of the study is to gain an in-depth understanding of PWUD experiences with decriminalization. Four total assessments are planned over five years, with new cohorts of PWUD recruited from across the province and with attempts for equal representation from each of the five provincial health authorities.

Preliminary themes that have emerged to date:

Quantitative Sub-Study

Quantitative data will be analyzed from a variety of sources (i.e., Statistics Canada, the BC Centres for Disease Control (BCCDC), and the Canadian Institutes for Health Information (CIHI.)) from 2013 to 2027 to examine the impacts of decriminalization on the health of PWUD pre- and post-policy implementation. Indicators will include opioid agonist treatment (OAT) prescriptions, overdose prevention services utilization, hospitalizations due to illicit drug overdoses, paramedic-attended illicit drug overdoses, overdose deaths, and load per capita of drugs in wastewater. Data analysis is expected to begin in mid-2024.

Summary of quantitative results to date:

Police and the Criminal Justice System

This sub-study will use quantitative analyses and qualitative interviews to examine criminal justice impacts and experiences with decriminalization among the police and criminal justice system.

Qualitative Sub-Study

Qualitative interviews with police will be conducted over five years with new cohorts of police recruited from across the province to gain an in-depth understanding of police experiences with decriminalization. Data collection began in November 2023, but results are not yet available.

Quantitative Sub-Study

Quantitative data will be analyzed from Statistics Canada (i.e., the Uniform Crime Reporting Survey (UCRS) and the Integrated Criminal Court Survey (ICCS)) from 2013 to 2027 to examine the impacts of decriminalization on police and criminal justice system-related indicators pre- and post-policy implementation. Indicators will include police-reported illegal drug-related offenses and illegal drug-related criminal charges. Data analysis is expected to begin in mid-2024.

Summary of quantitative results to date:

General Public

This sub-study will evaluate the impact of decriminalization policy on the public through public opinion surveys distributed to a representative sample of adults in B.C. Surveys are expected to begin in January 2024.

Health Services System

This sub-study will examine the impacts of decriminalization on harm reduction and opioid agonist therapy (OAT) services by collecting province-wide survey data on harm reduction and OAT service operations (e.g., service utilization, clientele socio-demographics, referral pathways, funding, etc.). Surveys will be completed by service representatives. In-depth follow-up interviews will also be conducted with a subset of participants. It is expected that the survey will launch in January 2024.

Economic Impacts

This sub-study will evaluate the economic impact of decriminalization. This includes estimating the economic burden of drug use in B.C., and the cost and impacts of interventions. Comparing the costs pre- and post-decriminalization will allow the researchers to calculate the return on investment for the decriminalization policy. Although final results won’t be available until the end of the five-year study, the researchers hope to provide some information throughout the study to inform potential cost-saving decision making.

Knowledge Triangulation

This sub-study will comprise two projects:

Conclusion and Next Steps

This research has the potential to inform policy discussions, revisions, or recommendations related to the decriminalization of illicit drugs in B.C. and other jurisdictions considering implementing decriminalization legislation.

The team will continue to progress on the six sub-studies highlighted in this update, conducting interviews, surveys, collecting data and analyzing and submitting results for publication when available.

The next update is expected in spring/summer 2024.

For More Information

For more about this project visit CIHR’s website or the CRISM Ontario website.

More information on CIHR’s Research in Substance Use initiative or by email: rsu-rst@cihr-irsc.gc.ca

More information on the CIHR Institute of Neurosciences, Mental Health and Addiction or by email: INMHA-INSMT@cihr-irsc.gc.ca.

Date modified: